Avista to buy Boston Scientific units for $425m

DLJ spinout Avista Capital Partners has made its fifth investment in the healthcare industry, with its agreement to buy the fluid management and venous access businesses of Boston Scientific.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this